デフォルト表紙
市場調査レポート
商品コード
1447776

プレフィルドシリンジ市場:2024-2034年

Pre-Filled Syringes Market Report 2024-2034

出版日: | 発行: Visiongain | ページ情報: 英文 329 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: GBPを日本円(税抜)に換算
本日の銀行送金レート: 1GBP=197.21円

ご注意:
Single UserとTeamライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

プレフィルドシリンジ市場:2024-2034年
出版日: 2024年03月05日
発行: Visiongain
ページ情報: 英文 329 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のプレフィルドシリンジの市場規模は、2034年にかけてCAGR 9.5%で成長すると予測されています。

プレフィルド注射器の技術的進歩:

プレフィルド注射器は主に病院の救急部門や特定の慢性疾患の管理に使用されています。これらの薬剤は、関節リウマチ、糖尿病、癌、自己免疫疾患などの慢性疾患の治療によく使用されています。先進の治療法では正確な投与と厳格な安全対策を必要とすることが多く、プレフィルドシリンジには理想的な適合性がります。これらのシリンジは、利便性、正確性、無菌性を提供し、患者は汚染のリスクを減らしながら正しい投与を受けることができます。慢性疾患を管理するための生物製剤の需要が高まる中、プレフィルドシリンジは好ましい送達方法として台頭し、患者のアドヒアランスと治療成果を高めると同時に、廃棄物を最小限に抑え、医療全体の効率を向上させています。

患者の利便性とコンプライアンスの向上:

患者の利便性とコンプライアンスは、プレフィルドシリンジの採用と使用を促進する上で重要な役割を果たします。プレフィルドシリンジは、特に患者の利便性と使いやすさの点で、従来のバイアルやアンプルよりも大きな利点を提供します。プレフィルドシリンジを使用することで、患者は手作業で薬剤を抽出する必要がなくなり、準備時間の短縮と投与の簡素化が可能になります。この合理化されたプロセスは、利便性を高めるだけでなく、処方された治療レジメンを患者が遵守することを促します。複雑な投与手順や注射針の取り扱いに対する恐怖感など、服薬コンプライアンスに対する潜在的な障壁を排除することで、プレフィルドシリンジは治療成績の向上と患者満足度の向上に貢献します。全体として、患者の利便性とコンプライアンスへの注目は、医療環境におけるプレフィルドシリンジの継続的な成長と採用の主要な推進力となっています。

当レポートでは、世界のプレフィルドシリンジの市場を調査し、市場概要、市場成長への影響因子および市場機会の分析、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 レポート概要

第2章 エグゼクティブサマリー

第3章 市場概要

  • 主な調査結果
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 市場機会
  • COVID-19の影響分析
  • ポーターのファイブフォース分析
  • PEST分析

第4章 プレフィルドシリンジ市場の分析:タイプ別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • 従来型シリンジ
  • セーフティシリンジ
    • 市場規模の推移・予測:地域別
    • 市場シェア:地域別

第5章 プレフィルドシリンジ市場の分析:材料別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • ガラス
  • プラスチック
  • ステンレス鋼
  • エラストマー
    • 市場規模の推移・予測:地域別
    • 市場シェア:地域別

第6章 プレフィルドシリンジ市場の分析:設計別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • シングルチャンバー
  • デュアルチャンバー
  • カスタマイズ
    • 市場規模の推移・予測:地域別
    • 市場シェア:地域別

第7章 プレフィルドシリンジ市場の分析:送達別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • 静脈内
  • 皮下
  • 筋肉内
  • その他
    • 市場規模の推移・予測:地域別
    • 市場シェア:地域別

第8章 プレフィルドシリンジ市場の分析:用途別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • 糖尿病
  • 関節リウマチ
  • アナフィラキシー
  • その他
    • 市場規模の推移・予測:地域別
    • 市場シェア:地域別

第9章 プレフィルドシリンジ市場の分析:地域別

  • 主要調査結果
  • 市場規模の推移・予測

第10章 北米のプレフィルドシリンジ市場の分析

第11章 欧州のプレフィルドシリンジ市場の分析

第12章 アジア太平洋のプレフィルドシリンジ市場の分析

第13章 ラテンアメリカのプレフィルドシリンジ市場の分析

第14章 中東・アフリカのプレフィルドシリンジ市場の分析

第15章 企業プロファイル

  • 競合情勢
  • 戦略的展望
  • Baxter International Inc.
  • BD
  • Biocon
  • Cardinal Health
  • Catalent, Inc.
  • Datwyler Holding Inc.
  • Debiotech S.A.
  • Elcam Medical
  • Fresenius Kabi AG
  • Gerresheimer AG
  • Micsafe Med(Jiangsu Micsafe Medical Technology Co., Ltd)
  • MedXL Inc.
  • Nipro Medical Corporation
  • Owen Mumford Ltd
  • Scandinavian Health Limited(SHL)Group
  • Schott AG
  • Stevanato Group
  • Terumo Corporation
  • Vetter Pharma
  • West Pharmaceutical Services, Inc.

第16章 総論・推奨事項

  • Visiongainによる総論
  • 参入企業への推奨事項
図表

List of Tables

  • Table 1 Pre-Filled Syringes Market Snapshot, 2024 & 2034 (US$ Million, CAGR %)
  • Table 2 Pre-Filled Syringes Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 3 Pre-Filled Syringes Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 4 Pre-Filled Syringes Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 5 Pre-Filled Syringes Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 6 Pre-Filled Syringes Market Forecast by Type, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 7 Conventional Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 8 Safety Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 9 Pre-Filled Syringes Market Forecast by Material, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 10 Glass Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 11 Plastic Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 12 Stainless Steel Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 13 Elastomer Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 14 Pre-Filled Syringes Market Forecast by Design, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 15 Single-chamber Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 16 Dual-chamber Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 17 Customized Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 18 Pre-Filled Syringes Market Delivery, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 19 Intravenous Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 20 Subcutaneous Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 21 Intramuscular Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 22 Others Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 23 Pre-Filled Syringes Market Application, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 24 Diabetes Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 25 Rheumatoid Arthritis Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 26 Anaphylaxis Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 27 Other Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 28 Pre-Filled Syringes Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 29 North America Pre-Filled Syringes Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 30 North America Pre-Filled Syringes Market Forecast by Type, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 31 North America Pre-Filled Syringes Market Forecast by Material, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 32 North America Pre-Filled Syringes Market Forecast by Design, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 33 Pre-Filled Syringes Market Delivery, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 34 North America Pre-Filled Syringes Market Application, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 35 U.S Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 36 Canada Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 37 Europe Pre-Filled Syringes Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 38 Pre-Filled Syringes Market Forecast by Type, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 39 Europe Pre-Filled Syringes Market Forecast by Material, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 40 Europe Pre-Filled Syringes Market Forecast by Design, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 41 Europe Pre-Filled Syringes Market Delivery, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 42 Europe Pre-Filled Syringes Market Application, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 43 Germany Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 44 France Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 45 UK Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 46 Italy Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 47 Spain Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 48 Russia Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 49 Poland Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 50 Belgium Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 51 Rest of Europe Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 52 Asia Pacific Pre-Filled Syringes Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 53 Asia Pacific Pre-Filled Syringes Market Forecast by Type, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 54 Asia Pacific Pre-Filled Syringes Market Forecast by Material, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 55 Asia Pacific Pre-Filled Syringes Market Forecast by Design, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 56 Asia Pacific Pre-Filled Syringes Market Delivery, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 57 Asia Pacific Pre-Filled Syringes Market Application, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 58 Japan Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 59 China Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 60 India Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 61 Australia Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 62 South Korea Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 63 Singapore Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 64 Taiwan Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 65 Rest of Asia Pacific Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 66 Latin America Pre-Filled Syringes Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 67 Latin America Pre-Filled Syringes Market Forecast by Type, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 68 Latin America Pre-Filled Syringes Market Forecast by Material, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 69 Latin America Pre-Filled Syringes Market Forecast by Design, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 70 Latin America Pre-Filled Syringes Market Delivery, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 71 Latin America Pre-Filled Syringes Market by Application, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 72 Brazil Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 73 Mexico Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 74 Argentina Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 75 Colombia Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 76 Rest of Latin America Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 77 MEA Pre-Filled Syringes Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 78 MEA Pre-Filled Syringes Market Forecast by Type, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 79 MEA Pre-Filled Syringes Market Forecast by Material, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 80 MEA Pre-Filled Syringes Market Forecast by Design, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 81 MEA Pre-Filled Syringes Market Delivery, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 82 MEA Pre-Filled Syringes Market by Application, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 83 GCC Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 84 South Africa Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 85 Rest of MEA Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 86 Strategic Outlook
  • Table 87 Baxter International Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 88 Baxter International Inc.: Product Benchmarking
  • Table 89 Baxter International Inc.: Strategic Outlook
  • Table 90 BD : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 91 BD: Product Benchmarking
  • Table 92 BD. Strategic Outlook
  • Table 93 Biocon : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 94 Biocon: Product Benchmarking
  • Table 95 Biocon: Strategic Outlook
  • Table 96 Cardinal Health : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 97 Cardinal Health: Product Benchmarking
  • Table 98 Cardinal Health: Strategic Outlook
  • Table 99 Catalent, Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 100 Catalent Inc: Product Benchmarking
  • Table 101 Catalent Inc: Strategic Outlook
  • Table 102 Datwyler Holding Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 103 Datwyler Holding Inc: Product Benchmarking
  • Table 104 Datwyler Holding Inc: Strategic Outlook
  • Table 105 Debiotech S.A.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 106 Debiotech SA: Product Benchmarking
  • Table 107 Debiotech SA: Strategic Outlook
  • Table 108 Elcam Medical: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 109 Elcam Medical: Product Benchmarking
  • Table 110 Fresenius Kabi AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 111 Fresenius Kabi AG: Product Benchmarking
  • Table 112 Fresenius Kabi AG: Strategic Outlook
  • Table 113 Gerresheimer AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 114 Gerresheimer AG: Product Benchmarking
  • Table 115 Gerresheimer AG: Strategic Outlook
  • Table 116 Micsafe Med (Jiangsu Micsafe Medical Technology Co., Ltd): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 117 Micsafe Med (Jiangsu Micsafe Medical Technology Co., Ltd).: Product Benchmarking
  • Table 118 MedXL Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 119 MedXL Inc.: Product Benchmarking
  • Table 120 MedXL Inc.: Strategic Outlook
  • Table 121 Nipro Medical Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 122 Nipro Medical Corporation: Product Benchmarking
  • Table 123 Nipro Medical Corporation.: Strategic Outlook
  • Table 124 Owen Mumford Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 125 Owen Mumford: Product Benchmarking
  • Table 126 Owen Mumford.: Strategic Outlook
  • Table 127 Scandinavian Health Limited (SHL) Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 128 Scandinavian Health Limited (SHL): Product Benchmarking
  • Table 129 Scandinavian Health Limited (SHL).: Strategic Outlook
  • Table 130 Schott AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 131 Schott AG: Product Benchmarking
  • Table 132 Schott AG: Strategic Outlook
  • Table 133 Stevanato Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 134 Stevanato Group: Product Benchmarking
  • Table 135 Stevanato Group: Strategic Outlook
  • Table 136 Terumo Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 137 Terumo Corporation: Product Benchmarking
  • Table 138 Terumo Corporation: Strategic Outlook
  • Table 139 Vetter Pharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 140 Vetter Pharma: Product Benchmarking
  • Table 141 West Pharmaceutical Services, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 142 West Pharmaceutical Services, Inc.: Product Benchmarking
  • Table 143 West Pharmaceutical Services, Inc.: Strategic Outlook

List of Figures

  • Figure 1 Pre-Filled Syringes Market Segmentation
  • Figure 2 Pre-Filled Syringes Market by Type: Market Attractiveness Index
  • Figure 3 Pre-Filled Syringes Market by Material: Market Attractiveness Index
  • Figure 4 Pre-Filled Syringes Market by Design: Market Attractiveness Index
  • Figure 5 Pre-Filled Syringes Market by Delivery: Market Attractiveness Index
  • Figure 6 Pre-Filled Syringes Market by Application: Market Attractiveness Index
  • Figure 7 Pre-Filled Syringes Market Attractiveness Index by Region
  • Figure 8 Pre-Filled Syringes Market: Market Dynamics
  • Figure 9 Pre-Filled Syringes Market by Region, 2024-2034 (US$ Million, AGR %): "V" Shaped Recovery
  • Figure 10 Pre-Filled Syringes Market by Region, 2024-2034 (US$ Million, AGR %): "U" Shaped Recovery
  • Figure 11 Pre-Filled Syringes Market by Region, 2024-2034 (US$ Million, AGR %): "W" Shaped Recovery
  • Figure 12 Pre-Filled Syringes Market by Region, 2024-2034 (US$ Million, AGR %): "L" Shaped Recovery
  • Figure 13 Pre-filled Syringes Market: Porter's Five Forces Analysis
  • Figure 14 Pre-Filled Syringes Market: PEST Analysis
  • Figure 15 Pre-Filled Syringes Market by Type: Market Attractiveness Index
  • Figure 16 Pre-Filled Syringes Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
  • Figure 17 Pre-Filled Syringes Market Share Forecast by Type, 2024, 2029, 2034 (%)
  • Figure 18 Conventional Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 19 Conventional Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 20 Safety Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 21 Safety Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 22 Pre-Filled Syringes Market by Material: Market Attractiveness Index
  • Figure 23 Pre-Filled Syringes Market Forecast by Material, 2024-2034 (US$ Million, AGR %)
  • Figure 24 Pre-Filled Syringes Market Share Forecast by Material, 2024, 2029, 2034 (%)
  • Figure 25 Glass Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 26 Glass Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 27 Plastic Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 28 Plastic Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 29 Stainless Steel Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 30 Stainless Steel Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 31 Elastomer Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 32 Elastomer Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 33 Pre-Filled Syringes Market by Design: Market Attractiveness Index
  • Figure 34 Pre-Filled Syringes Market Forecast by Design, 2024-2034 (US$ Million, AGR %)
  • Figure 35 Pre-Filled Syringes Market Share Forecast by Design, 2024, 2029, 2034 (%)
  • Figure 36 Single-chamber Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 37 Single-chamber Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 38 Dual-chamber Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 39 Dual-chamber Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 40 Customized Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 41 Customized Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 42 Pre-Filled Syringes Market by Delivery: Market Attractiveness Index
  • Figure 43 Pre-Filled Syringes Market Forecast by Delivery, 2024-2034 (US$ Million, AGR %)
  • Figure 44 Pre-Filled Syringes Market Share Forecast by Delivery, 2024, 2029, 2034 (%)
  • Figure 45 Intravenous Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 46 Pharmacies Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 47 Subcutaneous Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 48 Subcutaneous Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 49 Intramuscular Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 50 Intramuscular Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 51 Others Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 52 Others Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 53 Pre-Filled Syringes Market by Application: Market Attractiveness Index
  • Figure 54 Pre-Filled Syringes Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
  • Figure 55 Pre-Filled Syringes Market Share Forecast by Application, 2024, 2029, 2034 (%)
  • Figure 56 Diabetes Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 57 Diabetes Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 58 Rheumatoid Arthritis Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 59 Rheumatoid Arthritis Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 60 Anaphylaxis Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 61 Anaphylaxis Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 62 Other Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 63 Other Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 64 Pre-Filled Syringes Market Forecast by Region 2023 and 2033 (Revenue, CAGR %)
  • Figure 65 Pre-Filled Syringes Market Share Forecast by Region 2024, 2029, 2034 (%)
  • Figure 66 Pre-Filled Syringes Market by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 67 North America Pre-Filled Syringes Market Attractiveness Index
  • Figure 68 North America Pre-Filled Syringes Market by Region, 2024, 2029 & 2034 (US$ Million)
  • Figure 69 North America Pre-Filled Syringes Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
  • Figure 70 North America Pre-Filled Syringes Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 71 North America Pre-Filled Syringes Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
  • Figure 72 North America Pre-Filled Syringes Market Share Forecast by Type, 2024 & 2034 (%)
  • Figure 73 North America Pre-Filled Syringes Market Forecast by Material, 2024-2034 (US$ Million, AGR %)
  • Figure 74 North America Pre-Filled Syringes Market Share Forecast by Material, 2024 & 2034 (%)
  • Figure 75 North America Pre-Filled Syringes Market Forecast by Design, 2024-2034 (US$ Million, AGR %)
  • Figure 76 North America Pre-Filled Syringes Market Share Forecast by Design, 2024 & 2034 (%)
  • Figure 77 North America Pre-Filled Syringes Market Forecast by Delivery, 2024-2034 (US$ Million, AGR %)
  • Figure 78 North America Pre-Filled Syringes Market Share Forecast by Delivery, 2024 & 2034 (%)
  • Figure 79 North America Pre-Filled Syringes Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
  • Figure 80 North America Pre-Filled Syringes Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 81 U.S. Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 82 Canada Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 83 Europe Pre-Filled Syringes Market Attractiveness Index
  • Figure 84 Europe Pre-Filled Syringes Market by Region, 2024, 2029 & 2034 (US$ Million)
  • Figure 85 Europe Pre-Filled Syringes Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
  • Figure 86 Europe Pre-Filled Syringes Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 87 Europe Pre-Filled Syringes Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
  • Figure 88 Europe Pre-Filled Syringes Market Share Forecast by Type, 2024 & 2034 (%)
  • Figure 89 Europe Pre-Filled Syringes Market Forecast by Material, 2024-2034 (US$ Million, AGR %)
  • Figure 90 Europe Pre-Filled Syringes Market Share Forecast by Material, 2024 & 2034 (%)
  • Figure 91 Europe Pre-Filled Syringes Market Forecast by Design, 2024-2034 (US$ Million, AGR %)
  • Figure 92 Europe Pre-Filled Syringes Market Share Forecast by Design, 2024 & 2034 (%)
  • Figure 93 Europe Pre-Filled Syringes Market Forecast by Delivery, 2024-2034 (US$ Million, AGR %)
  • Figure 94 Europe Pre-Filled Syringes Market Share Forecast by Delivery, 2024 & 2034 (%)
  • Figure 95 Europe Pre-Filled Syringes Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
  • Figure 96 Europe Pre-Filled Syringes Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 97 Germany Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 98 France Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 99 UK Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 100 Italy Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 101 Spain Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 102 Russia Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 103 Poland Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 104 Belgium Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 105 Rest of Europe Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 106 Asia Pacific Pre-Filled Syringes Market Attractiveness Index
  • Figure 107 Asia Pacific Pre-Filled Syringes Market by Region, 2024, 2029 & 2034 (US$ Million)
  • Figure 108 Asia Pacific Pre-Filled Syringes Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
  • Figure 109 Asia Pacific Pre-Filled Syringes Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 110 Asia Pacific Pre-Filled Syringes Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
  • Figure 111 Asia Pacific Pre-Filled Syringes Market Share Forecast by Type, 2024 & 2034 (%)
  • Figure 112 Asia Pacific Pre-Filled Syringes Market Forecast by Material, 2024-2034 (US$ Million, AGR %)
  • Figure 113 Asia Pacific Pre-Filled Syringes Market Share Forecast by Material, 2024 & 2034 (%)
  • Figure 114 Asia Pacific Pre-Filled Syringes Market Forecast by Design, 2024-2034 (US$ Million, AGR %)
  • Figure 115 Asia Pacific Pre-Filled Syringes Market Share Forecast by Design, 2024 & 2034 (%)
  • Figure 116 Asia Pacific Pre-Filled Syringes Market Forecast by Delivery, 2024-2034 (US$ Million, AGR %)
  • Figure 117 Asia Pacific Pre-Filled Syringes Market Share Forecast by Delivery, 2024 & 2034 (%)
  • Figure 118 Asia Pacific Pre-Filled Syringes Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
  • Figure 119 Asia Pacific Pre-Filled Syringes Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 120 Japan Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 121 China Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 122 India Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 123 Australia Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 124 South Korea Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 125 Singapore Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 126 Taiwan Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 127 Rest of Asia Pacific Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 128 Latin America Pre-Filled Syringes Market Attractiveness Index
  • Figure 129 Latin America Pre-Filled Syringes Market by Region, 2024, 2029 & 2034 (US$ Million)
  • Figure 130 Latin America Pre-Filled Syringes Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
  • Figure 131 Latin America Pre-Filled Syringes Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 132 Latin America Pre-Filled Syringes Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
  • Figure 133 Latin America Pre-filled syringes Market Share Forecast by Type, 2024 & 2034 (%)
  • Figure 134 Latin America Pre-Filled Syringes Market Forecast by Material, 2024-2034 (US$ Million, AGR %)
  • Figure 135 Latin America Pre-Filled Syringes Market Share Forecast by Material, 2024 & 2034 (%)
  • Figure 136 Latin America Pre-Filled Syringes Market Forecast by Design, 2024-2034 (US$ Million, AGR %)
  • Figure 137 Latin America Pre-Filled Syringes Market Share Forecast by Design, 2024 & 2034 (%)
  • Figure 138 Latin America Pre-Filled Syringes Market Forecast by Delivery, 2024-2034 (US$ Million, AGR %)
  • Figure 139 Latin America Pre-Filled Syringes Market Share Forecast by Delivery, 2024 & 2034 (%)
  • Figure 140 Latin America Pre-Filled Syringes Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
  • Figure 141 Latin America Pre-Filled Syringes Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 142 Brazil Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 143 Mexico Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 144 Argentina Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 145 Colombia Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 146 Rest of Latin America Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 147 MEA Pre-Filled Syringes Market Attractiveness Index
  • Figure 148 MEA Pre-Filled Syringes Market by Region, 2024, 2029 & 2034 (US$ Million)
  • Figure 149 MEA Pre-Filled Syringes Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
  • Figure 150 MEA Pre-Filled Syringes Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 151 MEA Pre-Filled Syringes Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
  • Figure 152 MEA Pre-Filled Syringes Market Share Forecast by Type, 2024 & 2034 (%)
  • Figure 153 MEA Pre-Filled Syringes Market Forecast by Material, 2024-2034 (US$ Million, AGR %)
  • Figure 154 MEA Pre-Filled Syringes Market Share Forecast by Material, 2024 & 2034 (%)
  • Figure 155 MEA Pre-Filled Syringes Market Forecast by Design, 2024-2034 (US$ Million, AGR %)
  • Figure 156 MEA Pre-Filled Syringes Market Share Forecast by Design, 2024 & 2034 (%)
  • Figure 157 MEA Pre-Filled Syringes Market Forecast by Delivery, 2024-2034 (US$ Million, AGR %)
  • Figure 158 MEA Pre-Filled Syringes Market Share Forecast by Delivery, 2024 & 2034 (%)
  • Figure 159 MEA Pre-Filled Syringes Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
  • Figure 160 MEA Pre-Filled Syringes Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 161 GCC Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 162 South Africa Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 163 Rest of MEA Pre-Filled Syringes Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 164 Pre-Filled Syringes Market Company Share, 2022
  • Figure 165 Baxter International Inc.: Net Revenue, 2017-2022 (US$ Million, AGR%)
  • Figure 166 Baxter International Inc.: R&D, 2017-2022 (US$ Million, AGR%)
  • Figure 167 Baxter International Inc.: Regional Market Shares, 2022
  • Figure 168 BD: Net Revenue, 2017-2023 (US$ Million, AGR%)
  • Figure 169 BD: R&D, 2017-2023 (US$ Million, AGR%)
  • Figure 170 BD: Regional Market Shares, 2023
  • Figure 171 Biocon: Net Revenue, 2017-2023 (US$ Million, AGR%)
  • Figure 172 Biocon: R&D, 2017-2023 (US$ Million, AGR%)
  • Figure 173 Biocon: Regional Market Shares, 2023
  • Figure 174 Cardinal Health: Net Revenue, 2017-2023 (US$ Million, AGR%)
  • Figure 175 Cardinal Health: Regional Market Shares, 2022
  • Figure 176 Catalent Inc: Net Revenue, 2017-2023 (US$ Million, AGR%)
  • Figure 177 Catalent Inc: R&D, 2017-2023 (US$ Million, AGR%)
  • Figure 178 Datwyler Holding Inc: Net Revenue, 2017-2022 (US$ Million, AGR%)
  • Figure 179 Datwyler Holding Inc: R&D, 2017-2022 (US$ Million, AGR%)
  • Figure 180 Datwyler Holding Inc: Regional Market Shares, 2022
  • Figure 181 Fresenius Kabi AG: Net Revenue, 2017-2022 (US$ Million, AGR%)
  • Figure 182 Fresenius Kabi AG: R&D, 2017-2022 (US$ Million, AGR%)
  • Figure 183 Fresenius Kabi AG: Regional Market Shares, 2022
  • Figure 184 Gerresheimer AG: Net Revenue, 2017-2022 (US$ Million, AGR%)
  • Figure 185 Gerresheimer AG: R&D, 2017-2022 (US$ Million, AGR%)
  • Figure 186 Gerresheimer AG: Regional Market Shares, 2022
  • Figure 187 Nipro Medical Corporation: Net Revenue, 2017-2022 (US$ Million, AGR%)
  • Figure 188 Nipro Medical Corporation: R&D, 2017-2022 (US$ Million, AGR%)
  • Figure 189 Nipro Medical Corporation: Regional Market Shares, 2022
  • Figure 190 Schott AG: Net Revenue, 2020-2022 (US$ Million, AGR%)
  • Figure 191 Schott AG: R&D, 2020-2022 (US$ Million, AGR%)
  • Figure 192 Schott AG: Regional Market Shares, 2023
  • Figure 193 Stevanato Group: Net Revenue, 2020-2022 (US$ Million, AGR%)
  • Figure 194 Stevanato Group: R&D, 2020-2022 (US$ Million, AGR%)
  • Figure 195 Terumo Corporation: Net Revenue, 2017-2023 (US$ Million, AGR%)
  • Figure 196 Terumo Corporation: R&D, 2017-2023 (US$ Million, AGR%)
  • Figure 197 Terumo Corporation: Regional Market Shares, 2022
  • Figure 198 West Pharmaceutical Services, Inc.: Net Revenue, 2017-2022 (US$ Million, AGR%)
  • Figure 199 West Pharmaceutical Services, Inc.: R&D, 2017-2022 (US$ Million, AGR%)
  • Figure 200 West Pharmaceutical Services, Inc.: Regional Market Shares, 2022
目次
Product Code: PHA1313

The global Pre-Filled Syringes market is estimated to grow at a CAGR of 9.5% by 2034

The Pre-Filled Syringes Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Technological Advancements in Pre-filled Injectors

Pre-filled injectors find application primarily in hospital emergency departments and for managing specific chronic conditions. These drugs are often used to treat chronic conditions such as rheumatoid arthritis, diabetes, cancer, and autoimmune disorders. This trend will contribute to market growth during the forecast period include the increasing demand for biotechnology drugs presenting expanded opportunities for biotech industry growth. The advanced therapies, often requiring precise dosing and stringent safety measures, find an ideal match in prefilled syringes. These syringes offer convenience, accuracy, and sterility, ensuring patients receive the correct dosage with reduced risk of contamination. With the rising demand for biologics to manage chronic conditions, prefilled syringes emerge as a preferred delivery method, enhancing patient adherence and treatment outcomes while minimizing waste and improving overall healthcare efficiency.

Increase in Patient Convenience and Compliance

Patient convenience and compliance play crucial roles in driving adoption and usage of prefilled syringes. Prefilled syringes offer significant advantages over traditional vials and ampoules, particularly in terms of convenience and ease of use for patients. With prefilled syringes, patients can avoid the need for manual drawing of medication, reducing preparation time and simplifying administration. This streamlined process not only enhances convenience but also encourages patient compliance with prescribed treatment regimens. By eliminating potential barriers to adherence, such as complicated dosing procedures or fear of needle handling, prefilled syringes contribute to better treatment outcomes and improved patient satisfaction. Overall, the focus on patient convenience and compliance serves as a key driver in the continued growth and adoption of prefilled syringes in healthcare settings.

What Questions Should You Ask before Buying a Market Research Report?

How is the Pre-Filled Syringes Market evolving?

What is driving and restraining the Pre-Filled Syringes Market?

How will each Pre-Filled Syringes submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?

How will the market shares for each Pre-Filled Syringes submarket develop from 2024 to 2034?

What will be the main driver for the overall market from 2024 to 2034?

Will leading Pre-Filled Syringes Markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?

How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?

Who are the leading players and what are their prospects over the forecast period?

What are the Pre-Filled Syringes projects for these leading companies?

How will the industry evolve during the period between 2024 and 2034? What are the implications of Pre-Filled Syringes projects taking place now and over the next 10 years?

Is there a greater need for product commercialisation to further scale the Pre-Filled Syringes Market?

Where is the Pre-Filled Syringes Market heading and how can you ensure you are at the forefront of the market?

What are the best investment options for new product and service lines?

What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Pre-Filled Syringes Market today, and over the next 10 years:

Our 329-page report provides 143 tables and 200 charts/graphs exclusively to you.

The report highlights key lucrative areas in the industry so you can target them - NOW.

It contains in-depth analysis of global, regional and national sales and growth.

It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the Pre-Filled Syringes Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2034 and other analyses reveal commercial prospects

In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.

You will find original analyses, with business outlooks and developments.

Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Pre-Filled Syringes prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, "V", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report

By Type

Conventional

Safety

By Material

Glass

Plastic

Stainless Steel

Elastomer

By Design

Single-chamber

Dual-chamber

Customized

By Delivery

Intravenous

Subcutaneous

Intramuscular

Others

By Application

Diabetes

Rheumatoid Arthritis

Anaphylaxis

Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 28 leading national markets:

North America

U.S.

Canada

Europe

Germany

UK

France

Spain

Italy

Russia

Poland

Belgium

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Singapore

Taiwan

Rest of Asia Pacific

Latin America

Brazil

Mexico

Colombia

Argentina

Rest of Latin America

MEA

GCC

South Africa

Rest of MEA

The report also includes profiles and for some of the leading companies in the Pre-Filled Syringes Market, 2024 to 2034, with a focus on this segment of these companies' operations.

Leading companies profiled in the report

Baxter International Inc.

BD

Biocon

Cardinal Health

Catalent, Inc.

Datwyler Holding Inc.

Debiotech S.A.

Elcam Medical

Fresenius Kabi AG

Gerresheimer AG

Jiangsu Micsafe Medical Technology Co., Ltd

MedXL Inc

Nipro Medical Corporation

Owen Mumford Ltd

Scandinavian Health Limited (SHL) Group

Schott AG

Stevanato Group

Terumo Corporation

Vetter Pharma

West Pharmaceutical Services, Inc.

Overall world revenue for Pre-Filled Syringes Market, 2024 to 2034 in terms of value the market will surpass US$5,000.0 million in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Pre-Filled Syringes Market, 2024 to 2034 report help you?

In summary, our 320+ page report provides you with the following knowledge:

Revenue forecasts to 2034 for Pre-Filled Syringes Market, 2024 to 2034, with forecasts for material, design, type, delivery and application, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.

Revenue forecasts to 2034 for five regional and 27 key national markets - See forecasts for the Pre-Filled Syringes Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

Prospects for established firms and those seeking to enter the market - including company profiles for 20 of the major companies involved in the Pre-Filled Syringes Market, 2024 to 2034.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Pre-Filled Syringes Market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Pre-Filled Syringes Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report for?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 Emerging Movement Towards Home-based Healthcare
      • 3.2.1.2 Rising Uptake of Injectable Medications
      • 3.2.1.3 Innovative Solutions Addressing the Escalating Need for Pre-Filled Syringes
    • 3.2.2 Market Restraining Factors
      • 3.2.2.1 Challenges in the Manufacturing Process
      • 3.2.2.2 Presence of Alternative Drug Administration Techniques
      • 3.2.2.3 Sterilization Difficulties and the Presence of More Economical Alternatives
    • 3.2.3 Market Opportunities
      • 3.2.3.1 Expansion of Biologicals and Biosimilars
      • 3.2.3.2 Surge in the Need for Pre-Filled Injectable Drugs
      • 3.2.3.3 Favourable Opportunities in Biotech Industry
  • 3.3 COVID-19 Impact Analysis
  • 3.4 Porter's Five Forces Analysis
    • 3.4.1 Bargaining Power of Suppliers
    • 3.4.2 Bargaining Power of Buyers
    • 3.4.3 Competitive Rivalry
    • 3.4.4 Threat from Substitutes
    • 3.4.5 Threat of New Entrants
  • 3.5 PEST Analysis

4 Pre-Filled Syringes Market Analysis by Type

  • 4.1 Key Findings
  • 4.2 Type Segment: Market Attractiveness Index
  • 4.3 Pre-Filled Syringes Market Size Estimation and Forecast by Type
  • 4.4 Conventional
    • 4.4.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.4.2 Market Share by Region, 2024 & 2034 (%)
  • 4.5 Safety
    • 4.5.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.5.2 Market Share by Region, 2024 & 2034 (%)

5 Pre-Filled Syringes Market Analysis by Material

  • 5.1 Key Findings
  • 5.2 Material Segment: Market Attractiveness Index
  • 5.3 Pre-Filled Syringes Market Size Estimation and Forecast by Material
  • 5.4 Glass
    • 5.4.1 Market Size by Region, 2024-2034 (US$ Million)
    • 5.4.2 Market Share by Region, 2024 & 2034 (%)
  • 5.5 Plastic
    • 5.5.1 Market Size by Region, 2024-2034 (US$ Million)
    • 5.5.2 Market Share by Region, 2024 & 2034 (%)
  • 5.6 Stainless Steel
    • 5.6.1 Market Size by Region, 2024-2034 (US$ Million)
    • 5.6.2 Market Share by Region, 2024 & 2034 (%)
  • 5.7 Elastomer
    • 5.7.1 Market Size by Region, 2024-2034 (US$ Million)
    • 5.7.2 Market Share by Region, 2024 & 2034 (%)

6 Pre-Filled Syringes Market Analysis by Design

  • 6.1 Design Segment: Market Attractiveness Index
  • 6.2 Pre-Filled Syringes Market Size Estimation and Forecast by Design
  • 6.3 Single-chamber
    • 6.3.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.3.2 Market Share by Region, 2024 & 2034 (%)
  • 6.4 Dual-chamber
    • 6.4.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.4.2 Market Share by Region, 2024 & 2034 (%)
  • 6.5 Customized
    • 6.5.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.5.2 Market Share by Region, 2024 & 2034 (%)

7 Pre-Filled Syringes Market Analysis by Delivery

  • 7.1 Key Findings
  • 7.2 Delivery Segment: Market Attractiveness Index
  • 7.3 Pre-Filled Syringes Market Size Estimation and Forecast by Delivery
  • 7.4 Intravenous
    • 7.4.1 Market Size by Region, 2024-2034 (US$ Million)
    • 7.4.2 Market Share by Region, 2024 & 2034 (%)
  • 7.5 Subcutaneous
    • 7.5.1 Market Size by Region, 2024-2034 (US$ Million)
    • 7.5.2 Market Share by Region, 2024 & 2034 (%)
  • 7.6 Intramuscular
    • 7.6.1 Market Size by Region, 2024-2034 (US$ Million)
    • 7.6.2 Market Share by Region, 2024 & 2034 (%)
  • 7.7 Others
    • 7.7.1 Market Size by Region, 2024-2034 (US$ Million)
    • 7.7.2 Market Share by Region, 2024 & 2034 (%)

8 Pre-Filled Syringes Market Analysis by Application

  • 8.1 Key Findings
  • 8.2 Application Segment: Market Attractiveness Index
  • 8.3 Pre-Filled Syringes Market Size Estimation and Forecast by Application
  • 8.4 Diabetes
    • 8.4.1 Market Size by Region, 2024-2034 (US$ Million)
    • 8.4.2 Market Share by Region, 2024 & 2034 (%)
  • 8.5 Rheumatoid Arthritis
    • 8.5.1 Market Size by Region, 2024-2034 (US$ Million)
    • 8.5.2 Market Share by Region, 2024 & 2034 (%)
  • 8.6 Anaphylaxis
    • 8.6.1 Market Size by Region, 2024-2034 (US$ Million)
    • 8.6.2 Market Share by Region, 2024 & 2034 (%)
  • 8.7 Other
    • 8.7.1 Market Size by Region, 2024-2034 (US$ Million)
    • 8.7.2 Market Share by Region, 2024 & 2034 (%)

9 Pre-Filled Syringes Market Analysis by Region

  • 9.1 Key Findings
  • 9.2 Regional Market Size Estimation and Forecast

10 North America Pre-Filled Syringes Market Analysis

  • 10.1 Key Findings
  • 10.2 North America Pre-Filled Syringes Market Attractiveness Index
  • 10.3 North America Pre-Filled Syringes Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 10.4 North America Pre-Filled Syringes Market Size Estimation and Forecast by Country
  • 10.5 North America Pre-Filled Syringes Market Size Estimation and Forecast by Type
  • 10.6 North America Pre-Filled Syringes Market Size Estimation and Forecast by Material
  • 10.7 North America Pre-Filled Syringes Market Size Estimation and Forecast by Design
  • 10.8 North America Pre-Filled Syringes Market Size Estimation and Forecast by Delivery
  • 10.9 North America Pre-Filled Syringes Market Size Estimation and Forecast by Application
  • 10.10 U.S. Pre-Filled Syringes Market Analysis
  • 10.11 Canada Pre-Filled Syringes Market Analysis

11 Europe Pre-Filled Syringes Market Analysis

  • 11.1 Key Findings
  • 11.2 Europe Pre-Filled Syringes Market Attractiveness Index
  • 11.3 Europe Pre-Filled Syringes Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 11.4 Europe Pre-Filled Syringes Market Size Estimation and Forecast by Country
  • 11.5 Europe Pre-Filled Syringes Market Size Estimation and Forecast by Type
  • 11.6 Europe Pre-Filled Syringes Market Size Estimation and Forecast by Material
  • 11.7 Europe Pre-Filled Syringes Market Size Estimation and Forecast by Design
  • 11.8 Europe Pre-Filled Syringes Market Size Estimation and Forecast by Delivery
  • 11.9 Europe Pre-Filled Syringes Market Size Estimation and Forecast by Application
  • 11.10 Germany Pre-Filled Syringes Market Analysis
  • 11.11 France Pre-Filled Syringes Market Analysis
  • 11.12 UK Pre-Filled Syringes Market Analysis
  • 11.13 Italy Pre-Filled Syringes Market Analysis
  • 11.14 Spain Pre-Filled Syringes Market Analysis
  • 11.15 Russia Pre-Filled Syringes Market Analysis
  • 11.16 Poland Pre-Filled Syringes Market Analysis
  • 11.17 Belgium Pre-Filled Syringes Market Analysis
  • 11.18 Rest of Europe Pre-Filled Syringes Market Analysis

12 Asia Pacific Pre-Filled Syringes Market Analysis

  • 12.1 Key Findings
  • 12.2 Asia Pacific Pre-Filled Syringes Market Attractiveness Index
  • 12.3 Asia Pacific Pre-Filled Syringes Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 12.4 Asia Pacific Pre-Filled Syringes Market Size Estimation and Forecast by Country
  • 12.5 Asia Pacific Pre-Filled Syringes Market Size Estimation and Forecast by Type
  • 12.6 Asia Pacific Pre-Filled Syringes Market Size Estimation and Forecast by Material
  • 12.7 Asia Pacific Pre-Filled Syringes Market Size Estimation and Forecast by Design
  • 12.8 Asia Pacific Pre-Filled Syringes Market Size Estimation and Forecast by Delivery
  • 12.9 Asia Pacific Pre-Filled Syringes Market Size Estimation and Forecast by Application
  • 12.10 Japan Pre-Filled Syringes Market Analysis
  • 12.11 China Pre-Filled Syringes Market Analysis
  • 12.12 India Pre-Filled Syringes Market Analysis
  • 12.13 Australia Pre-Filled Syringes Market Analysis
  • 12.14 South Korea Pre-Filled Syringes Market Analysis
  • 12.15 Singapore Pre-Filled Syringes Market Analysis
  • 12.16 Taiwan Pre-Filled Syringes Market Analysis
  • 12.17 Rest of Asia Pacific Pre-Filled Syringes Market Analysis

13 Latin America Pre-Filled Syringes Market Analysis

  • 13.1 Key Findings
  • 13.2 Latin America Pre-Filled Syringes Market Attractiveness Index
  • 13.3 Latin America Pre-Filled Syringes Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 13.4 Latin America Pre-Filled Syringes Market Size Estimation and Forecast by Country
  • 13.5 Latin America Pre-Filled Syringes Market Size Estimation and Forecast by Type
  • 13.6 Latin America Pre-Filled Syringes Market Size Estimation and Forecast by Material
  • 13.7 Latin America Pre-Filled Syringes Market Size Estimation and Forecast by Design
  • 13.8 Latin America Pre-Filled Syringes Market Size Estimation and Forecast by Delivery
  • 13.9 Latin America Pre-Filled Syringes Market Size Estimation and Forecast by Application
  • 13.10 Brazil Pre-Filled Syringes Market Analysis
  • 13.11 Mexico Pre-Filled Syringes Market Analysis
  • 13.12 Argentina Pre-Filled Syringes Market Analysis
  • 13.13 Colombia Pre-Filled Syringes Market Analysis
  • 13.14 Rest of Latin America Pre-Filled Syringes Market Analysis

14 MEA Pre-Filled Syringes Market Analysis

  • 14.1 Key Findings
  • 14.2 MEA Pre-Filled Syringes Market Attractiveness Index
  • 14.3 MEA Pre-Filled Syringes Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 14.4 MEA Pre-Filled Syringes Market Size Estimation and Forecast by Country
  • 14.5 MEA Pre-Filled Syringes Market Size Estimation and Forecast by Type
  • 14.6 MEA Pre-Filled Syringes Market Size Estimation and Forecast by Material
  • 14.7 MEA Pre-Filled Syringes Market Size Estimation and Forecast by Design
  • 14.8 MEA Pre-Filled Syringes Market Size Estimation and Forecast by Delivery
  • 14.9 MEA Pre-Filled Syringes Market Size Estimation and Forecast by Application
  • 14.10 GCC Pre-Filled Syringes Market Analysis
  • 14.11 South Africa Pre-Filled Syringes Market Analysis
  • 14.12 Rest of MEA Pre-Filled Syringes Market Analysis

15 Company Profiles

  • 15.1 Competitive Landscape, 2022
  • 15.2 Strategic Outlook
  • 15.3 Baxter International Inc.
    • 15.3.1 Company Snapshot
    • 15.3.2 Company Overview
    • 15.3.3 Financial Analysis
      • 15.3.3.1 Net Revenue, 2017-2022
      • 15.3.3.2 R&D, 2017-2022
      • 15.3.3.3 Regional Market Shares, 2022
    • 15.3.4 Product Benchmarking
    • 15.3.5 Strategic Outlook
  • 15.4 BD
    • 15.4.1 Company Snapshot
    • 15.4.2 Company Overview
    • 15.4.3 Financial Analysis
      • 15.4.3.1 Net Revenue, 2017-2023
      • 15.4.3.2 R&D, 2017-2023
      • 15.4.3.3 Regional Market Shares, 2023
    • 15.4.4 Product Benchmarking
    • 15.4.5 Strategic Outlook
  • 15.5 Biocon
    • 15.5.1 Company Snapshot
    • 15.5.2 Company Overview
    • 15.5.3 Financial Analysis
      • 15.5.3.1 Net Revenue, 2017-2023
      • 15.5.3.2 R&D, 2017-2023
      • 15.5.3.3 Regional Market Shares, 2023
    • 15.5.4 Product Benchmarking
    • 15.5.5 Strategic Outlook
  • 15.6 Cardinal Health
    • 15.6.1 Company Snapshot
    • 15.6.2 Company Overview
    • 15.6.3 Financial Analysis
      • 15.6.3.1 Net Revenue, 2017-2023
      • 15.6.3.2 Regional Market Shares, 2022
    • 15.6.4 Product Benchmarking
    • 15.6.5 Strategic Outlook
  • 15.7 Catalent, Inc.
    • 15.7.1 Company Snapshot
    • 15.7.2 Company Overview
    • 15.7.3 Financial Analysis
      • 15.7.3.1 Net Revenue, 2017-2023
      • 15.7.3.2 R&D, 2017-2023
    • 15.7.4 Product Benchmarking
    • 15.7.5 Strategic Outlook
  • 15.8 Datwyler Holding Inc.
    • 15.8.1 Company Snapshot
    • 15.8.2 Company Overview
    • 15.8.3 Financial Analysis
      • 15.8.3.1 Net Revenue, 2017-2022
      • 15.8.3.2 R&D, 2017-2022
      • 15.8.3.3 Regional Market Shares, 2022
    • 15.8.4 Product Benchmarking
    • 15.8.5 Strategic Outlook
  • 15.9 Debiotech S.A.
    • 15.9.1 Company Snapshot
    • 15.9.2 Company Overview
    • 15.9.3 Product Benchmarking
    • 15.9.4 Strategic Outlook
  • 15.10 Elcam Medical
    • 15.10.1 Company Snapshot
    • 15.10.2 Company Overview
    • 15.10.3 Product Benchmarking
  • 15.11 Fresenius Kabi AG
    • 15.11.1 Company Snapshot
    • 15.11.2 Company Overview
    • 15.11.3 Financial Analysis
      • 15.11.3.1 Net Revenue, 2017-2022
      • 15.11.3.2 R&D, 2017-2022
      • 15.11.3.3 Regional Market Shares, 2022
    • 15.11.4 Product Benchmarking
    • 15.11.5 Strategic Outlook
  • 15.12 Gerresheimer AG
    • 15.12.1 Company Snapshot
    • 15.12.2 Company Overview
    • 15.12.3 Financial Analysis
      • 15.12.3.1 Net Revenue, 2017-2022
      • 15.12.3.2 R&D, 2017-2022
      • 15.12.3.3 Regional Market Shares, 2022
    • 15.12.4 Product Benchmarking
    • 15.12.5 Strategic Outlook
  • 15.13 Micsafe Med (Jiangsu Micsafe Medical Technology Co., Ltd)
    • 15.13.1 Company Snapshot
    • 15.13.2 Company Overview
    • 15.13.3 Product Benchmarking
  • 15.14 MedXL Inc.
    • 15.14.1 Company Snapshot
    • 15.14.2 Company Overview
    • 15.14.3 Product Benchmarking
    • 15.14.4 Strategic Outlook
  • 15.15 Nipro Medical Corporation
    • 15.15.1 Company Snapshot
    • 15.15.2 Company Overview
    • 15.15.3 Financial Analysis
      • 15.15.3.1 Net Revenue, 2017-2022
      • 15.15.3.2 R&D, 2017-2022
      • 15.15.3.3 Regional Market Shares, 2022
    • 15.15.4 Product Benchmarking
    • 15.15.5 Strategic Outlook
  • 15.16 Owen Mumford Ltd
    • 15.16.1 Company Snapshot
    • 15.16.2 Company Overview
    • 15.16.3 Product Benchmarking
    • 15.16.4 Strategic Outlook
  • 15.17 Scandinavian Health Limited (SHL) Group
    • 15.17.1 Company Snapshot
    • 15.17.2 Company Overview
    • 15.17.3 Product Benchmarking
    • 15.17.4 Strategic Outlook
  • 15.18 Schott AG
    • 15.18.1 Company Snapshot
    • 15.18.2 Company Overview
    • 15.18.3 Financial Analysis
      • 15.18.3.1 Net Revenue, 2020-2022
      • 15.18.3.2 R&D, 2020-2022
      • 15.18.3.3 Regional Market Shares, 2023
    • 15.18.4 Product Benchmarking
    • 15.18.5 Strategic Outlook
  • 15.19 Stevanato Group
    • 15.19.1 Company Snapshot
    • 15.19.2 Company Overview
    • 15.19.3 Financial Analysis
      • 15.19.3.1 Net Revenue, 2020-2022
      • 15.19.3.2 R&D, 2020-2022
    • 15.19.4 Product Benchmarking
    • 15.19.5 Strategic Outlook
  • 15.20 Terumo Corporation
    • 15.20.1 Company Snapshot
    • 15.20.2 Company Overview
    • 15.20.3 Financial Analysis
      • 15.20.3.1 Net Revenue, 2017-2023
      • 15.20.3.2 R&D, 2017-2023
      • 15.20.3.3 Regional Market Shares, 2022
    • 15.20.4 Product Benchmarking
    • 15.20.5 Strategic Outlook
  • 15.21 Vetter Pharma
    • 15.21.1 Company Snapshot
    • 15.21.2 Company Overview
    • 15.21.3 Product Benchmarking
  • 15.22 West Pharmaceutical Services, Inc.
    • 15.22.1 Company Snapshot
    • 15.22.2 Company Overview
    • 15.22.3 Financial Analysis
      • 15.22.3.1 Net Revenue, 2017-2022
      • 15.22.3.2 R&D, 2017-2022
      • 15.22.3.3 Regional Market Shares, 2022
    • 15.22.4 Product Benchmarking
    • 15.22.5 Strategic Outlook

16 Conclusion and Recommendations

  • 16.1 Concluding Remarks from Visiongain
  • 16.2 Recommendations for Market Players